Dr. Mehdi Noroozi at IMPrESS Perio Implant Center, now offers autogenous concentrated growth factors such as advanced Platelet Rich Fibrin (PRF) for many periodontal, implant and oral surgery procedures. Utilizing a small sample of the patient’s own blood, this therapy can enhance hard and soft tissue grafting procedures. Not only does the treatment reduce healing times, but it also decreases pain and swelling and improves overall patient experience with optimal treatment outcome. This innovative technology has been used in dentistry for over ten years with much success. PRF treatments have been used in areas other than dentistry as well. The treatments have received significant press in the sports medicine field, but are also prevalent in other parts of the medical world.
Platelet rich fibrin treatment has been widely used in heart surgery, orthopedics, oral and maxillofacial surgery, plastic surgery and dermatology. Dr. Mehdi Noroozi is proud to be of few periodontists in Canada to have been trained in advanced PRF treatments.
A second-generation form of blood-derived growth factor technology, advanced Platelet Rich Fibrin involves the creation of a thin, durable layer of platelet-rich fibrin. The proteins in the fibrin encourage swifter healing and wound closing and reduce the likelihood of infection. They are also particularly helpful in cases of multiple recession defects. Advanced PRF has a number of applications for periodontal and oral surgery including bone defects grafting, extractions, sinus lifts, gum grafts and more.
Advantages of Advanced-Platelet Rich Fibrin
Advanced-Platelet Rich Fibrin treatments can enhance the success rate of many oral surgery procedures such as gum grafting, bone grafting and implant surgery. Every patient’s product is processed from his own blood, and there are scientifically proven benefits such as increased healing abilities.
After centrifugation, the platelet releases specific growth factors, including transforming growth factor beta (TGF-B), platelet derived growth factor (PDGF), vaso-endothelial growth factor (VEGF) and epithelial growth factor (EGF). Each of these factors plays a specific role in new vascularization (formation of blood vessels) and hard and soft tissue healing. Since patients heal faster, they enjoy a smaller chance of infection, dry socket, failed grafting or failed implants.
If you are interested in this innovative new treatment, contact our office to book consultation with Dr. Mehdi Noroozi.
